Table 1.
Instrument | First author | Study group | Physical functioning | Physical role | Bodily pain | General health | Vitality | Social functioning | Emotional role | Mental health | PCS | MCS |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
AN | ||||||||||||
SF-36 | del Valle [16] | Traininga | 93.2 (7.5) | 67.6 (21.1) | 95.6 (7.4) | 70.7 (14.5) | 76.7 (15.3) | 66.1 (18.7) | 72.5 (24.3) | 73.2 (14.5) | 58.8 (14.0) | 44.2 (9.4) |
Controla | 83.2 (17.6) | 45.6 (39.8) | 59.7 (26.5) | 52.2 (21.0) | 51.3 (33.5) | 49.4 (28.3) | 56.8 (32.0) | 40.2 (25.2) | 44.3 (11.5) | 35.1 (16.8) | ||
Doll [17] | AN | 88.92 (11.40) | 73.75 (34.42) | 63.30 (21.48) | 53.26 (19.01) | 41.63 (19.15) | 72.37 (20.38) | 49.38 (42.03) | 52.57 (17.27) | 43.40 (9.02) | 45.54 (8.91) | |
Gonzalez-Pinto [19] | AN | 83.98 (13.2) | 61.70 (40.3) | 72.91 (25.6) | 57.42 (20.4) | 52.34 (23.6) | 63.56 (29.9) | 65.95 (40.2) | 49.29 (23.5) | 50.41 (8.2) | 36.25 (14.6) | |
Padierna [24] | AN-P | 88.9 (16.4) | 52.1 (43.3) | 64.9 (30.1) | 50.1 (23.1) | 44.5 (23.5) | 51.5 (30.1) | 41.7 (42.8) | 41.5 (23.4) | n.r. | n.r. | |
AN-R | 87.5 (15.4) | 62.0 (40.6) | 72.4 (22.7) | 51.6 (19.1) | 51.7 (22.0) | 62.3 (30.9) | 57.6 (42.3) | 47.8 (23.2) | n.r. | n.r. | ||
Rie [25] | AN | 80.2 (18.2) | 42.0 (37.7) | 65.9 (23.1) | 48.8 (21.3) | 39.5 (17.7) | 46.6 (22.5) | 29.5 (36.8) | 41.6 (16.6) | n.r. | n.r. | |
Turner [27] | AN | 68.9 (21.5) | 14.3 (25.4) | 42.0 (22.0) | 35 (18.8) | 18.2 (14.9) | 32.5 (24.8) | 21.4 (28.0) | 30.9 (22.0) | n.r. | n.r. | |
SF-12 | Mond [22] | AN-P | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 46.80 (10.03) | 26.96 (7.44) |
AN-R | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 45.38 (10.28) | 38.38 (11.05) | ||
BN | ||||||||||||
SF-36 | Doll [17] | BN | 90.62 (11.90) | 67.71 (35.99) | 72.44 (22.46) | 53.98 (19.93) | 42.85 (20.05) | 70.51 (21.32) | 35.47 (43.95) | 51.84 (18.05) | 47.20 (9.47) | 43.76 (9.35) |
Nickel [33] | Topiramatea | 67.2 (6.5) | 57.1 (6.0) | 59.8 (7.2) | 51.0 (5.3) | 52.3 (4.1) | 64.9 (6.2) | 61.2 (8.0) | 60.9 (6.1) | n.r. | n.r. | |
Placeboa | 65.4 (5.8) | 57.1 (5.3) | 61.5 (7.0) | 53.6 (5.5) | 53.3 (5.3) | 64.1 (7.7) | 57.6 (8.2) | 60.4 (6.2) | n.r. | n.r. | ||
Padierna [24] | BN | 89.5 (11.9) | 54.8 (41.4) | 63.3 (28.0) | 47.1 (21.0) | 44.9 (20.8) | 54.5 (28.1) | 41.8 (43.6) | 46.4 (23) | n.r. | n.r. | |
Rie [25] | BN | 84.5 (15.4) | 44.6 (39.2) | 67.8 (19.6) | 52.5 (17.5) | 36.2 (15.7) | 42.2 (26.4) | 22.2 (32.6) | 38.3 (16.9) | n.r. | n.r. | |
Turner [27] | BN | 80.0 (25.4) | 57.1 (44.0) | 60.8 (24.7) | 42.9 (22.0) | 27.4 (17.1) | 49.1 (30.6) | 30.8 (37.9) | 34.2 (17.8) | n.r. | n.r. | |
SF-12 | Mond [22] | BN | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 49.25 (10.07) | 27.60 (9.44) |
Mond [32] | OBEs | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 46.50 (10.21) | 36.34 (11.98) | |
SBEs | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 48.84 (10.82) | 36.28 (12.23) | ||
OBEs and SBEs | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 45.77 (11.64) | 36.58 (10.86) | ||
BED | ||||||||||||
SF-36 | de Zwaan [36] | Postoperative | 82.8 (16.4) | 61.1 (28.3) | 55.3 (26.0) | 42.4 (30.9) | 41.7 (25.9) | 72.4 (31.5) | 92.6 (22.3) | 59.1 (24.9) | 42.2 (8.9) | 45.7 (10.4) |
de Zwaan [37] | BED | 36.7 (13.3) | 23.5 (21.2) | 39.1 (13.9) | 39.1 (16.7) | 19.4 (13.3) | 51.4 (14.9) | 53.6 (43.2) | 68.4 (13.1) | 28.1 (6.8) | 44.7 (9.5) | |
Doll [17] | BED | 87.23 (11.55) | 52.49 (34.92) | 72.63 (21.79) | 55.83 (19.27) | 42.12 (19.43) | 72.28 (20.68) | 23.78 (42.57) | 52.78 (17.51) | 46.31 (9.12) | 40.83 (9.00) | |
Faulconbridge [38] | Bariatric surgerya | 34.9 (1.9) | 41.8 (1.7)b | 39.5 (1.6)b | 38.6 (1.7)b | 39.0 (1.6)b | 38.3 (2.0)b | 42.3 (1.7)b | 43.5 (1.8)b | 37.7 (1.7)b | 43.1 (1.6)b | |
Lifestyle modificationa | 37.3 (1.5) | 43.7 (1.5)b | 44.8 (1.6)b | 41.4 (1.4)b | 42.7 (1.4)b | 42.7 (1.7)b | 43.7 (1.8)b | 44.8 (1.7)b | 40.8 (1.3)b | 45.4 (2.0)b | ||
Marchesini [42] | CBT | 68 (23) | 60 (40) | 60 (28) | 55 (12) | 51 (21) | 63 (25) | 59 (41) | 58 (21) | 43 (10) | 42 (13) | |
Control | 71 (23) | 64 (40) | 61 (27) | 57 (10) | 51 (20) | 64 (26) | 57 (41) | 59 (21) | 44 (10) | 42 (12) | ||
Masheb [43] | BMI ≥30 kg/m2 | 69.9 (21.8) | 63.4 (39.8) | 56.7 (23.7) | 62.4 (18.8) | 37.6 (19.5) | 63.3 (27.6) | 49.8 (42.1) | 58.2 (15.9) | 45.3 (9.6) | 39.3 (10.6) | |
BMI <30 kg/m2 | 91.5 (8.5) | 79.3 (35.1) | 72.8 (22.8) | 74.7 (14.6) | 47.2 (19.9) | 77.2 (19.8) | 60.9 (42.2) | 62.3 (18.6) | 53.6 (9.4) | 41.0 (12.2) | ||
Padierna [24] | BED | 72.3 (22.7) | 46.9 (42.7) | 60.7 (30.9) | 50.7 (23.1) | 40.9 (21.5) | 52.2 (25.9) | 37.3 (45.5) | 44.5 (16.0) | n.r. | n.r. | |
SF-12 | Mond [22] | BED | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | n.r. | 40.18 (13.11) | 30.36 (7.96) |
Only studies in which eating disorder-specific SF-12/SF-36 scale and/or summary scores were presented are included in Table 1
AN anorexia nervosa, AN-P anorexia nervosa, purging type, AN-R anorexia nervosa, restricting type, BED binge eating disorder, BMI body mass index, BN bulimia nervosa, CBT cognitive behavioral therapy, MCS mental component summary, n.r. not reported, OBEs objective bulimic episodes, PCS physical component summary, SBEs subjective bulimic episodes, SD standard deviation, SF-12 Medical Outcomes Study Short-Form 12, SF-36 Medical Outcomes Study Short-Form 36
aBaseline data; bmean (standard error)